Constance Care (WAR:CCR) Other Current Receivables: zł0.01 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:CCR Constance Care SA WAR:CCR
22 GF Score
Price zł5.20
GF Value zł0.15
Valuation Significantly Overvalued
View Full Analysis

What is Constance Care Other Current Receivables?

Constance Care WAR:CCR 22 Other Current Receivables is zł0.01 Mil as of Mar. 2026. GuruFocus rates WAR:CCR with a GF Score™ of 22/100 and a GF Value™ of zł0.15 (Significantly Overvalued).

Constance Care's Other Current Receivables for the quarter that ended in Mar. 2026 was zł0.01 Mil.

Constance Care's quarterly Other Current Receivables declined from Sep. 2025 (zł0.01 Mil) to Dec. 2025 (zł0.01 Mil) but then stayed the same from Dec. 2025 (zł0.01 Mil) to Mar. 2026 (zł0.01 Mil).

Constance Care's annual Other Current Receivables increased from Dec. 2023 (zł0.00 Mil) to Dec. 2024 (zł0.02 Mil) but then declined from Dec. 2024 (zł0.02 Mil) to Dec. 2025 (zł0.01 Mil).


Constance Care Other Current Receivables Related Terms


Constance Care Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Constance Care's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Constance Care Other Current Receivables Chart

Constance Care Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial 0.04 0.03 0.00 0.02 0.01

Constance Care Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.01 0.01 0.01
WAR:CCR
22GF Score
Constance Care SA WAR:CCR
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Constance Care Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of zł0.01 Mil mean?
Constance Care (WAR:CCR) has a Other Current Receivables of zł0.01 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Constance Care and its competitors.
Is Constance Care's Other Current Receivables too high?
Constance Care's current Other Current Receivables is zł0.01 Mil. Overall, Constance Care has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Constance Care's Other Current Receivables compare to HCA and THC?
Constance Care's Other Current Receivables of zł0.01 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Constance Care and its competitors. Constance Care's current Other Current Receivables is zł0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Constance Care stock overvalued right now?
Based on GuruFocus' analysis, Constance Care (WAR:CCR) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.15, compared to a current price of zł5.20 — trading 3366.7% above its estimated fair value. The current Other Current Receivables is zł0.01 Mil. Constance Care's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Constance Care (WAR:CCR), the current Other Current Receivables is zł0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Constance Care (WAR:CCR) Overvalued in 2026?

Based on GuruFocus' analysis, Constance Care stock appears to be overvalued. The current stock price of zł5.20 is trading 3366.7% above its estimated GF Value™ of zł0.15. GuruFocus considers Constance Care to be Significantly Overvalued.

Key valuation signals for WAR:CCR:

  • Other Current Receivables: zł0.01 Mil
  • GF Value™: zł0.15 vs. price of zł5.20 (3366.7% above fair value)
  • GF Score™: 22/100

No single metric tells the full story. See the WAR:CCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Constance Care Business Description

Address ul. Dzialkowa 125, Kierszek, POL, 05-500
Constance Care SA conducts physiotherapeutic activities aimed at improving the quality of health and life of people suffering both from musculoskeletal disorders as a result of various random events, diseases or related to the aging of the body, as well as the rehabilitation of cognitive functions in children and adults.
22GF Score

Get the complete analysis for WAR:CCR

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł5.20
Price
zł0.15
GF Value